Neuroleptospirosis in patients presenting with primary central nervous system infection: A multicentre study

BACKGROUND: Leptospirosis is well-known to cause neurological involvement. However, data on the frequency of neuroleptospirosis as a cause of primary central nervous system (CNS) infections is sparse. METHODOLOGY/PRINCIPAL FINDINGS: An observational study was conducted in three regions in Sri Lanka between October 2021-March 2024. Patients with a primary diagnosis of meningitis, meningoencephalitis or encephalitis were recruited. Blood and cerebrospinal fluid (CSF) were analysed for pathogenic Leptospira DNA by real-time PCR, and serology by microscopic agglutination test (MAT) on admission and after 10-14 days. A confirmed case was a patient with evidence of CNS infection with positive CSF or blood PCR and/or 4-fold rise/single titre ≥1:320 in MAT. A total of 100 patients were studied with a median age of 55 (IQR 39.7 - 69.7) years and 52 (52%) males. Suspected clinical diagnoses were meningitis (n = 66,66%), meningoencephalitis (n = 22,22%) and encephalitis (n = 12,12%). Eleven (11%) patients were laboratory-confirmed as neuroleptospirosis; meningitis (n = 3), meningoencephalitis (n = 3), encephalitis (n = 5). Three patients had positive blood Leptospira PCR, one had positive blood and CSF Leptospira PCR, three had high initial MAT and four had a 4-fold rise in MAT. Neurological manifestations included headache (n = 8), seizures (n = 2), confusion (n = 7), photophobia (n = 4), neck stiffness (n = 6) and limb weakness (n = 5). Majority of patients with positive blood or CSF PCR for Leptospira (n = 3, 75%) did not have a CSF cellular reaction. The neuroleptospirosis group had a lower requirement for intensive care compared to other CNS infections (9% vs 13.5%) and recovered without residual neurological disability. There were no deaths in the neuroleptospirosis group compared to 11 (12.4%) deaths in other CNS infections. CONCLUSIONS: Leptospirosis is an important cause of primary CNS infections, and may lead to more favourable outcomes. It is important to consider leptospirosis as an aetiological agent in the laboratory workup of primary CNS infections in leptospirosis-prevalent settings.

Authors

Institutions

Publication Details

Journal
PLoS neglected tropical diseases
Published
2026-04-07
DOI
https://doi.org/10.1371/journal.pntd.0014183
Primary Topic
Leptospirosis research and findings
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroleptospirosis in patients presenting with primary central nervous system infection: A multicentre study

Udaya K. Ranawaka, Suresh Mendis, Lilani Karunanayake, Nilanka Perera et al.
PLoS neglected tropical diseases
Leptospirosis research and findings
article

Neuroleptospirosis in patients presenting with primary central nervous system infection: A multicentre study

Udaya K. Ranawaka, Suresh Mendis, Lilani Karunanayake, Nilanka Perera, Asanka Ratnayake, Varuna Abeyratne, Wimalasiri Uluwatta, Thisal Semina, M. Mujaheith, Nandana Dickmadugoda, Champika Gunawardena, Parami Rajapakse
article en

Abstract

BACKGROUND: Leptospirosis is well-known to cause neurological involvement. However, data on the frequency of neuroleptospirosis as a cause of primary central nervous system (CNS) infections is sparse. METHODOLOGY/PRINCIPAL FINDINGS: An observational study was conducted in three regions in Sri Lanka between October 2021-March 2024. Patients with a primary diagnosis of meningitis, meningoencephalitis or encephalitis were recruited. Blood and cerebrospinal fluid (CSF) were analysed for pathogenic Leptospira DNA by real-time PCR, and serology by microscopic agglutination test (MAT) on admission and after 10-14 days. A confirmed case was a patient with evidence of CNS infection with positive CSF or blood PCR and/or 4-fold rise/single titre ≥1:320 in MAT. A total of 100 patients were studied with a median age of 55 (IQR 39.7 - 69.7) years and 52 (52%) males. Suspected clinical diagnoses were meningitis (n = 66,66%), meningoencephalitis (n = 22,22%) and encephalitis (n = 12,12%). Eleven (11%) patients were laboratory-confirmed as neuroleptospirosis; meningitis (n = 3), meningoencephalitis (n = 3), encephalitis (n = 5). Three patients had positive blood Leptospira PCR, one had positive blood and CSF Leptospira PCR, three had high initial MAT and four had a 4-fold rise in MAT. Neurological manifestations included headache (n = 8), seizures (n = 2), confusion (n = 7), photophobia (n = 4), neck stiffness (n = 6) and limb weakness (n = 5). Majority of patients with positive blood or CSF PCR for Leptospira (n = 3, 75%) did not have a CSF cellular reaction. The neuroleptospirosis group had a lower requirement for intensive care compared to other CNS infections (9% vs 13.5%) and recovered without residual neurological disability. There were no deaths in the neuroleptospirosis group compared to 11 (12.4%) deaths in other CNS infections. CONCLUSIONS: Leptospirosis is an important cause of primary CNS infections, and may lead to more favourable outcomes. It is important to consider leptospirosis as an aetiological agent in the laboratory workup of primary CNS infections in leptospirosis-prevalent settings.

PLoS neglected tropical diseasesVol. 20(4)
University of Kelaniya (LK), University of Sri Jayewardenepura (LK), Colombo North Teaching Hospital (LK), National Hospital of Sri Lanka (LK), Medical Research Institute (LK)
Good health and well-being
Openalex Percentile: Top 30%
Leptospirosis research and findings
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.